Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.70 |
| ▸ | ACHE | P22303 | 2/20 | 0.62 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.61 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.54 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.54 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30924133 | 0.91 | ERCC1 (0.64) | EPHX2CACNA1GERCC1ERCC4P2RX7 | |
| SCHEMBL30924132 | 0.91 | ERCC1 (0.64) | EPHX2CACNA1GERCC1ERCC4P2RX7 | |
| SCHEMBL30924137 | 0.91 | EPHX2 (0.70) | EPHX2ACHECACNA1G | |
| SCHEMBL30924138 | 0.91 | EPHX2 (0.70) | EPHX2ACHECACNA1G | |
| SCHEMBL30924058 | 0.90 | EPHX2 (0.69) | EPHX2ACHECACNA1G | |
| SCHEMBL30924072 | 0.88 | EPHX2 (0.67) | EPHX2ACHECACNA1G | |
| SCHEMBL30924112 | 0.88 | EPHX2 (0.77) | EPHX2ACHE | |
| SCHEMBL30924015 | 0.88 | ERCC1 (0.57) | EPHX2CACNA1GERCC1ERCC4P2RX7 | |
| SCHEMBL30924093 | 0.88 | CACNA1G (0.58) | EPHX2CACNA1GERCC1ERCC4P2RX7 | |
| SCHEMBL30924107 | 0.85 | ERCC1 (0.60) | EPHX2CACNA1GERCC1ERCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4618985-A1 | DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN | Universitat De Barcelona (ES) | 2025-09-24 | — | — | EP | disclosed |
| WO-2024105234-A1 | DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN | UNIVERSITAT DE BARCELONA (ES) | 2024-05-23 | — | — | WO | disclosed |